Trial intelligence / Profile preview

Efficacy of electroporation combined with bleomycin in the treatment of keloids and hypertrophic scars: a pilot Phase 2 study

2009-013455-30Phase 2Active

Sponsor
ASST Spedali Civili di Brescia
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of bleomycin in keloid and Hypertrophic Scar (HS), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Change in lesion dimension. Started Oct 2009; status: active.

02

Drugs

bleomycin
03

Conditions

keloidHypertrophic Scar (HS)

Beyond the preview

Go deeper on 2009-013455-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-013455-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call